ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

Wiernik Loses Post At Einstein Following Unauthorized Trials

November 5, 1993

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

June 24, 2005

In Brief: New RFA, Program Announcements Coming Up Soon From BCDB for Radiation, Breast Cancer Studies

December 7, 1979

NCI selects nanotech centers for funding.

October 14, 2005

In Brief: Diane Fink Moves to ACS California Div.; Preisler Names Director Of Cancer Center In Cincinnati

February 10, 1989

Conferees Set NIH Funding At $30 Billion.

November 2, 2007